Search for dissertations about: "Serous"
Showing result 1 - 5 of 44 swedish dissertations containing the word Serous.
-
1. Tumour microenvironment in serous ovarian cancer
Abstract : Ovarian cancer is the seventh most common malignancy in women worldwide and the most lethal gynaecological malignancy in developed countries. The epithelial subtype is divided in five main histologic groups, of which the high-grade serous is the most common subtype. READ MORE
-
2. Immune modulation in serous epithelial ovarian cancer : focus on the role of tumor-derived exosomes
Abstract : Serous epithelial ovarian cancer (EOC) is a potent suppressor of the immune defense. Here, we studied interactions between EOC and the immune system that lead to escape from tumor immune surveillance. READ MORE
-
3. On the prognosis and treatment of early stage endometrial carcinoma : Studies with special reference to uterine papillary serous carcinoma
Abstract : The prognosis and therapy in the subgroup of endometrial malignancies called Uterine Papillary Serous Carcinoma (UPSC) was investigated. This entity constitutes about 6-8 % of all endometrial carcinomas clinical stage I but, as has been shown here, accounts for one third of the cancer mortality in the early stages of endometrial carcinoma. READ MORE
-
4. Mesothelial differentiation, mesothelioma and tumor markers in serous cavities
Abstract : Mesothelial cells covering the serous membranes are of mesodermal origin although they acquire several characteristics of epithelial cells. The cytological and histological diagnosis of malignant tumors in serous cavities is sometimes a major challenge: the main diagnostic alternatives are reactive benign mesothelium, mesothelioma and adenocarcinoma. READ MORE
-
5. New Prognostic Markers in Stage III Serous Ovarian Adenocarcinomas
Abstract : Ovarian carcinoma is the fifth most common cause of cancer death in Swedish women. Patients with advanced-stage disease respond differently to treatment, and the clinical outcome is difficult to predict for an individual patient. READ MORE